Modulating the Transport Characteristics of Bruch’s Membrane With Steroidal Glycosides and its Relevance to Age-Related Macular Degeneration (AMD)
The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
PURPOSE: Beneficial expectations of supplement therapies to increase the transport of nutrients, vitamins, and antioxidants across Bruch's membrane in AMD, by mass action alone, remain inconclusive. Therefore, the potential for targeting the transport pathways themselves to improve bidirectional exchange using amphipathic steroidal glycosides (ginsenosides) has been investigated. METHODS: Bruch's choroid preparations were mounted in modified Ussing chambers and basal levels of hydraulic conductivity (23 donors, age range, 12-89 years) and diffusional transport of FITC-albumin (21 donors, age range, 12-92 years) quantified. Then, following a 24-hour incubation with ginsenoside preparations, the transport parameters were re-evaluated and the resulting data analyzed with respect to aging and modulation by ginsenosides. RESULTS: Basal hydraulic conductivity of Bruch's showed an age-related exponential decline with a half-life of 19 years. Incubation with ginsenosides improved hydraulic conductivity with levels equivalent to donors 19 years younger. Across the age range examined, hydraulic conductivities were increased to 2.05-fold ± 0.38 (P < 0.001) of basal values. Diffusional transport of albumin across Bruch's also showed an age-related exponential decline with a half-life of 18 years. The decay curves were elevated on incubation with ginsenosides and diffusional rates were equivalent to donors 15 years younger. Diffusional rates were elevated 2.01-fold ± 0.49 over basal values (P < 0.001). CONCLUSIONS: Transport characteristics of human Bruch's can be improved by ginsenosides, facilitating the bidirectional exchange of nutrients and waste products across the membrane. With improved transport pathways, the need for supplement therapies becomes redundant. Slowed aging of Bruch's is expected to delay the onset and/or progression of AMD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With the thickening of the Bruch’s membrane, the access of vitamin A to the RPE and consequently photoreceptors is reduced, which causes similar consequences as in hypovitaminosis A [196,200].”
From The Role of Vitamin A in Retinal Diseases (2022) · cites this paper as [196]
In the citing paper
“In AMD, there is a marked thickening of the Bruch’s membrane, which reduces the permeability of nutrients and waste products through it [196,197].”
From The Role of Vitamin A in Retinal Diseases (2022) · cites this paper as [196]
Citations
Cites
Matrix metalloproteinases and their inhibitors in connective tissue remodeling
Woessner, J. F. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.8.1850705 · Cited by 3,282
Matrix Metalloproteinases: A Review
Birkedal-Hansen, H., Moore, W. G. I., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A., & Engler, J. A. (1993) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411930040020401 · Cited by 2,970
The matrix‐degrading metalloproteinases
Matrisian, L. M. (1992) · BioEssays · doi:10.1002/bies.950140705 · Cited by 1,364
A role for local inflammation in the formation of drusen in the aging eye
Anderson, D. H., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01624-0 · Cited by 1,087
Matrix metalloproteinases: structures, evolution, and diversification
Massova, I., Kotra, L. P., Fridman, R., & Mobashery, S. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1075 · Cited by 781
Accumulation of cholesterol with age in human Bruch's membrane.
Curcio, C. A., Millican, C. L., Bailey, T. A., & Kruth, H. S. (2001) · PubMed · Cited by 508
DEGRADATION OF GINSENOSIDES IN HUMANS AFTER ORAL ADMINISTRATION
Tawab, M. A., Bahr, U., Karas, M., Wurglics, M., & Schubert-Zsilavecz, M. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.8.1065 · Cited by 439
Antioxidant properties of a North American ginseng extract
Kitts, D. D., Wijewickreme, A. N., & Hu, C. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007078414639 · Cited by 434
Wang, A. L., Lukas, T. J., Yuan, M., Du, N., Tso, M. O., & Neufeld, A. H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004160 · Cited by 355
Cited by
Senescence in the pathogenesis of age-related macular degeneration
Blasiak, J. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03420-x · Cited by 183
“These and other observations support the potential of the MMP-based, laser- and drug-mediated therapeutic interventions in AMD [51, 52].”
ResultDynamic lipid turnover in photoreceptors and retinal pigment epithelium throughout life
Lewandowski, D., Sander, C. L., Tworak, A., Gao, F., Xu, Q., & Skowronska‐Krawczyk, D. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.101037 · Cited by 117
The Role of Vitamin A in Retinal Diseases
Sajovic, J., Meglič, A., Glavač, D., Markelj, Š., Hawlina, M., & Fakin, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031014 · Cited by 109
On the origin of proteins in human drusen: The meet, greet and stick hypothesis
Bergen, A. A., Arya, S., Koster, C., Pilgrim, M. G., Wiatrek-Moumoulidis, D., van der Spek, P. J., Hauck, S. M., Boon, C. J. F., Emri, E., Stewart, A. J., et al. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.12.003 · Cited by 101
Bruch’s membrane pathology: A mechanistic perspective
Murali, A., Krishnakumar, S., Subramanian, A., & Parameswaran, S. (2020) · European Journal of Ophthalmology · doi:10.1177/1120672120919337 · Cited by 47
“Hence, an approach targeting the transport system of the BrM is highly recommended as a therapeutic intervention to increase the efficacy of dietary antioxidant and nutrient supplements.(19)”
Background
Metadata
- Authors
- Lee, Y., Hussain, A. A., Seok, J.-H., Kim, S.-H., & Marshall, J.
- Affiliations
- University of London (GB)
- Chungnam National University (KR)
- Jeonbuk National University (KR)
- Corresponding author
- Hussain, Ali A.
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2015-12-31
- Volume
- 56
- Issue
- 13
- Pages
- 8403
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- OpenAlex
- W2230251251
- Cited by
- 26
- References
- 51
- Citations by year
- 2025: 4 · 2024: 6 · 2023: 1 · 2022: 2 · 2021: 4 · 2020: 3 · 2019: 1 · 2018: 4 · 2017: 1
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Investigative Ophthalmology & Visual Science (publishedVersion, public-domain)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Ginseng Biological Effects and Applications
- Keywords
- Bruch's membrane, age-related macular degeneration, ginsenosides, steroid glycosides, hydraulic conductivity, choroid, membrane transport, aging, nutrient exchange
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Aging, Biological Transport, Child, Female, Humans, Macular Degeneration, Male, Middle Aged, Bruch Membrane, Disease Progression, Ginsenosides, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.